preamble_15

Whereas the national institutes responsible for maintaining the reserve of antigen should cooperate with the Community Coordinating Institute for foot-and-mouth disease vaccines designated by Decision 91/665/EEC (3) in order to ensure the potency, safety and stability of the antigen, and vaccines produced therefrom, and to ensure that the quantity and sub-types kept are appropriate to the risk, on the basis, in particular, of information supplied by the reference laboratory for the identification of foot-and-mouth disease virus designated by Decision 89/531/EEC (4);

← preamble_14 · All articles · preamble_16 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-08 · Text as adopted (Official Journal); later amendments are not incorporated in this text.